Arcus Biosciences (RCUS) Return on Sales [ROS] (2017 - 2026)
Arcus Biosciences (RCUS) recorded Return on Sales [ROS] of -234.15% in Q2 2026, down 229.15 percentage points from -5.00% a year earlier but up 554.09 percentage points from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) Return on Sales [ROS] (2017 - 2026) Analysis & Trends
On a TTM basis, Arcus Biosciences' Return on Sales [ROS] came in at -415.38% as of Jun 30, 2026, down 286.38 percentage points year-over-year; for FY2025, it came in at -156.28%, down 28.37 percentage points from FY2024.
- Annual Return on Sales [ROS] has a five-year change of +2.70 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at -127.91% in FY2024 (+162.69 pp), -290.60% in FY2023 (-40.60 pp), -250.00% in FY2022 (-264.10 pp) and 14.10% in FY2021 (+173.07 pp).
- Quarterly Return on Sales [ROS] has ranged from -825.87% in Q3 2021 to 79.25% in Q4 2021 over the past five years.
- On a year-over-year basis, Return on Sales [ROS] rose in three of the last eight quarters, with an average year-over-year change of -135.95 percentage points.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 625.01 percentage points in Q4 2021, against a drop of 828.28 percentage points in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at -788.24% (Q1 2026), -345.45% (Q4 2025) and -546.15% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Arcus Biosciences | 3.11 Bn | -229.58 Mn | - | -234.15% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -234.15% |
| Mar 31, 2026 | -788.24% |
| Dec 31, 2025 | -345.45% |
| Sep 30, 2025 | -546.15% |
| Jun 30, 2025 | -5.00% |
| Mar 31, 2025 | -435.71% |
| Dec 31, 2024 | -396.15% |
| Sep 30, 2024 | -218.75% |
| Jun 30, 2024 | -271.79% |
| Mar 31, 2024 | -11.03% |
| Dec 31, 2023 | -293.55% |
| Sep 30, 2023 | -250.00% |
| Jun 30, 2023 | -286.21% |
| Mar 31, 2023 | -344.00% |
| Dec 31, 2022 | -217.65% |
| Sep 30, 2022 | -212.12% |
| Jun 30, 2022 | -255.56% |
| Mar 31, 2022 | -372.22% |
| Dec 31, 2021 | 79.25% |
| Sep 30, 2021 | -825.87% |
API Access
Arcus Biosciences Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();